Blackrock, Ireland

Paul John Ellis

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: International Business Machines Corporation. Active years: 2020-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul John Ellis: Innovator in Product Support and Risk Assessment

Introduction

Paul John Ellis is a notable inventor based in Blackrock, Ireland. He has made significant contributions to the field of product support and risk assessment through his innovative patents. With a total of 2 patents, Ellis has demonstrated his expertise and commitment to advancing technology in his area of work.

Latest Patents

Ellis's latest patents include a method for determining support costs for a scheduled release of a product. This computer-implemented method involves building a support profile based on historical data and calculating expected customer cases resulting from the product release. Another significant patent focuses on risk assessment in online collaborative environments. This invention involves parsing text content related to user issues and determining risk levels based on existing entries in a repository.

Career Highlights

Paul John Ellis is currently employed at International Business Machines Corporation (IBM), where he applies his innovative ideas to real-world challenges. His work has contributed to improving product support strategies and enhancing risk management processes.

Collaborations

Ellis has collaborated with notable coworkers, including John Carolan and Paulito Pedregosa Palmes. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions.

Conclusion

Paul John Ellis is a distinguished inventor whose work in product support and risk assessment has made a lasting impact in the technology sector. His innovative patents and collaborations reflect his dedication to advancing the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…